Perrigo Company plc (PRGO) financial statements and ratios from SEC XBRL: revenue $4.2B (TTM), net margin -33.5%, revenue growth -7.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $4.25B |
| Revenue (TTM) | $4.2B |
| Net Margin | -33.5% |
| Operating Margin (TTM) | -36.9% |
| Net Debt / EBITDA | -2.7 |
| Revenue Growth (YoY) | -7.2% |
| EPS Growth (YoY) | 5640.0% |
| FCF Growth (YoY) | 41.6% |
| Price / Book | 0.80 |
| Price / Sales | 0.48 |
| FCF Yield | 7.2% |
| Altman Z-Score | -0.08 (distress) |
| Piotroski F-Score | 4/9 |
| Piotroski checks passed | 4 of 9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
PRGO overview · PRGO earnings · PRGO KPIs · PRGO documents · PRGO ownership · PRGO peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.